Compare Stocks

Edge Therapeutics NASDAQ:EDGE

PDS Biotechnology Corp. engages in the development of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products PDS0101, is an off the shelf immunotherapeutic that is administered by subcutaneous injection. The company was founded by Frank K. Bedu-Addo on March 15, 2019 and is headquartered in Princeton, NJ.

Invesco Russell 1000 Quality Factor ETF BATS:OQAL

Direxion Daily Magnificent 7 Bear 1X Shares NYSEARCA:QQQD

The Direxion Daily Concentrated Qs Bear 1X Shares (QQQD) is an exchange-traded fund that is based on the Indxx Front of the Q index. The fund tracks -1x the daily price movements of an equal-weighted index of the seven largest NASDAQ-listed companies. QQQD was launched on Mar 7, 2024 and is issued by Direxion.

Ft Vest Us Eq Qua Max Buf NYSEARCA:SQMX

The FT Vest U.S. Equity Quarterly Max Buffer ETF (SQMX) is an exchange-traded fund that mostly invests in large cap equity. The fund aims to deliver returns that match the SPDR S&P 500 ETF Trust price performance up to a set upside cap, while providing a dynamic buffer of 5% or 7.5% against losses over a three-month period. The fund employs FLEX options to implement this strategy and resets its cap and buffer each quarter. SQMX was launched on Dec 20, 2024 and is issued by First Trust.